🔴 Generate Biomedicines is trading 4.64% down today with no confirmed catalyst

Generate Biomedicines is trading at $16.65, down 4.64%, with no clearly confirmed catalyst for the decline.

• At the Bernstein Healthcare Forum on September 23, 2026, the company discussed its AI drug-discovery platform and pipeline.
• The company acknowledged slow enrollment in its Phase III asthma study; available coverage does not explicitly connect those comments to the intraday decline.
• Broader equities were weaker, while biotech was rallying.